BioSample Run ReleaseDate LoadDate spots bases spots_with_mates avgLength size_MB AssemblyName download_path Experiment LibraryName LibraryStrategy LibrarySelection LibrarySource LibraryLayout InsertSize InsertDev Platform Model SRAStudy BioProject Study_Pubmed_id ProjectID Sample SampleType TaxID ScientificName SampleName g1k_pop_code source g1k_analysis_group Subject_ID Sex Disease Tumor Affection_Status Analyte_Type Histological_Type Body_Site CenterName Submission dbgap_study_accession Consent RunHash ReadHash uid title organization taxonomy sra geo cell line cell type genotype source_name treatment SAMN32812820 SRR23153399 2023-02-15T21:36:26Z 2023-01-20T12:58:29Z 54984000 11106768000 54984000 202 3443 https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-3/SRR023/23153/SRR23153399/SRR23153399.lite.1 SRX19104014 GSM6945998 RNA-Seq cDNA TRANSCRIPTOMIC PAIRED 0 0 ILLUMINA Illumina NovaSeq 6000 SRP418448 PRJNA925859 925859 SRS16516323 simple 9606 Homo sapiens GSM6945998 no BIOENGINEERING, MCGILL UNIVERSITY SRA1577397 public 5632E3A370BB47727759B429FBD0C18B 03C462654785C043CD37122468E86379 32812820 TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.5μM, Day 4 [Pac0.5muMR2] Bioengineering, McGill University 9606 SRS16516323 GSM6945998 MDA-MB-231 Triple Negative Breast Cancer WT MDA-MB-231 0.5μM Paclitaxel SAMN32812821 SRR23153400 2023-02-15T21:36:26Z 2023-01-20T13:06:14Z 67108960 13556009920 67108960 202 4221 https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-3/SRR023/23153/SRR23153400/SRR23153400.lite.1 SRX19104013 GSM6945997 RNA-Seq cDNA TRANSCRIPTOMIC PAIRED 0 0 ILLUMINA Illumina NovaSeq 6000 SRP418448 PRJNA925859 925859 SRS16516324 simple 9606 Homo sapiens GSM6945997 no BIOENGINEERING, MCGILL UNIVERSITY SRA1577397 public E7EF52F0099CB441F1E7A0E8B09F63D0 C087A1CB2EF08A6AF3B9032350FC00B3 32812821 TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.5μM, Day 4 [Pac0.5muMR1] Bioengineering, McGill University 9606 SRS16516324 GSM6945997 MDA-MB-231 Triple Negative Breast Cancer WT MDA-MB-231 0.5μM Paclitaxel SAMN32812822 SRR23153401 2023-02-15T21:36:26Z 2023-01-20T13:07:14Z 70448298 14230556196 70448298 202 4400 https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-3/SRR023/23153/SRR23153401/SRR23153401.lite.1 SRX19104012 GSM6945996 RNA-Seq cDNA TRANSCRIPTOMIC PAIRED 0 0 ILLUMINA Illumina NovaSeq 6000 SRP418448 PRJNA925859 925859 SRS16516322 simple 9606 Homo sapiens GSM6945996 no BIOENGINEERING, MCGILL UNIVERSITY SRA1577397 public A3A0C36457FC46195F831BA9BB044DD1 0EA469834A1EEBD956DFC676AF7ECFEC 32812822 TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.05μM, Day 4 [Pac0.05muMR2] Bioengineering, McGill University 9606 SRS16516322 GSM6945996 MDA-MB-231 Triple Negative Breast Cancer WT MDA-MB-231 0.05μM Paclitaxel SAMN32812823 SRR23153402 2023-02-15T21:36:26Z 2023-01-20T13:07:06Z 71162403 14374805406 71162403 202 4457 https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-3/SRR023/23153/SRR23153402/SRR23153402.lite.1 SRX19104011 GSM6945995 RNA-Seq cDNA TRANSCRIPTOMIC PAIRED 0 0 ILLUMINA Illumina NovaSeq 6000 SRP418448 PRJNA925859 925859 SRS16516321 simple 9606 Homo sapiens GSM6945995 no BIOENGINEERING, MCGILL UNIVERSITY SRA1577397 public 600E4123D2D73FFB14189281B557905F 2DDF72EDB4AA21443D41438E996A491D 32812823 TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.05μM, Day 4 [Pac0.05muMR1] Bioengineering, McGill University 9606 SRS16516321 GSM6945995 MDA-MB-231 Triple Negative Breast Cancer WT MDA-MB-231 0.05μM Paclitaxel SAMN32812824 SRR23153403 2023-02-15T21:36:26Z 2023-01-20T12:49:48Z 80272588 16215062776 80272588 202 5018 https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-3/SRR023/23153/SRR23153403/SRR23153403.lite.1 SRX19104010 GSM6945994 RNA-Seq cDNA TRANSCRIPTOMIC PAIRED 0 0 ILLUMINA Illumina NovaSeq 6000 SRP418448 PRJNA925859 925859 SRS16516320 simple 9606 Homo sapiens GSM6945994 no BIOENGINEERING, MCGILL UNIVERSITY SRA1577397 public AEEE9DF40FFE1E37D22022F3A9982364 418CDBB9C54818928FA7FA0507D67501 32812824 TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.005μM, Day 4 [Pac0.005muMR2] Bioengineering, McGill University 9606 SRS16516320 GSM6945994 MDA-MB-231 Triple Negative Breast Cancer WT MDA-MB-231 0.005μM Paclitaxel SAMN32812825 SRR23153404 2023-02-15T21:36:26Z 2023-01-20T13:06:26Z 84477050 17064364100 84477050 202 5274 https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-3/SRR023/23153/SRR23153404/SRR23153404.lite.1 SRX19104009 GSM6945993 RNA-Seq cDNA TRANSCRIPTOMIC PAIRED 0 0 ILLUMINA Illumina NovaSeq 6000 SRP418448 PRJNA925859 925859 SRS16516319 simple 9606 Homo sapiens GSM6945993 no BIOENGINEERING, MCGILL UNIVERSITY SRA1577397 public BA11214F424894EB6E18ED52EB9F1F00 A56C2AD836894959438C39D116E2948C 32812825 TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.005μM, Day 4 [Pac0.005muMR1] Bioengineering, McGill University 9606 SRS16516319 GSM6945993 MDA-MB-231 Triple Negative Breast Cancer WT MDA-MB-231 0.005μM Paclitaxel SAMN32812826 SRR23153405 2023-02-15T21:36:26Z 2023-01-20T13:05:59Z 64456085 13020129170 64456085 202 4032 https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-3/SRR023/23153/SRR23153405/SRR23153405.lite.1 SRX19104008 GSM6945992 RNA-Seq cDNA TRANSCRIPTOMIC PAIRED 0 0 ILLUMINA Illumina NovaSeq 6000 SRP418448 PRJNA925859 925859 SRS16516318 simple 9606 Homo sapiens GSM6945992 no BIOENGINEERING, MCGILL UNIVERSITY SRA1577397 public FD5E8B33BC5F7A2134BCBBBA640DC6A9 2EFB9A23A242E47D22065C95B0052AA4 32812826 TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.0005μM, Day 4 [Pac0.0005muMR2] Bioengineering, McGill University 9606 SRS16516318 GSM6945992 MDA-MB-231 Triple Negative Breast Cancer WT MDA-MB-231 0.0005μM Paclitaxel SAMN32812827 SRR23153406 2023-02-15T21:36:26Z 2023-01-20T13:01:56Z 77529554 15660969908 77529554 202 4856 https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-3/SRR023/23153/SRR23153406/SRR23153406.lite.1 SRX19104007 GSM6945991 RNA-Seq cDNA TRANSCRIPTOMIC PAIRED 0 0 ILLUMINA Illumina NovaSeq 6000 SRP418448 PRJNA925859 925859 SRS16516317 simple 9606 Homo sapiens GSM6945991 no BIOENGINEERING, MCGILL UNIVERSITY SRA1577397 public 535AE3759254A3DCD9C505341836AE64 2DD2279AF5C87C04D07F3B85E861AFA5 32812827 TNBC cells from MDA-MB-231 cell line, treated with Paclitaxel, dose: 0.0005μM, Day 4 [Pac0.0005muMR1] Bioengineering, McGill University 9606 SRS16516317 GSM6945991 MDA-MB-231 Triple Negative Breast Cancer WT MDA-MB-231 0.0005μM Paclitaxel SAMN32812828 SRR23153407 2023-02-15T21:36:26Z 2023-01-20T13:01:30Z 56926679 11499189158 56926679 202 3570 https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-3/SRR023/23153/SRR23153407/SRR23153407.lite.1 SRX19104006 GSM6945990 RNA-Seq cDNA TRANSCRIPTOMIC PAIRED 0 0 ILLUMINA Illumina NovaSeq 6000 SRP418448 PRJNA925859 925859 SRS16516315 simple 9606 Homo sapiens GSM6945990 no BIOENGINEERING, MCGILL UNIVERSITY SRA1577397 public DBFFE3AEAE7DE2EDAED28B65A466707B 87908B243B108F9422C840E1F5CB9D00 32812828 TNBC cells from MDA-MB-231 cell line, no treatment, Day 4 [C2R2] Bioengineering, McGill University 9606 SRS16516315 GSM6945990 MDA-MB-231 Triple Negative Breast Cancer WT MDA-MB-231 no treatment SAMN32812829 SRR23153408 2023-02-15T21:36:26Z 2023-01-20T12:57:17Z 63647491 12856793182 63647491 202 3966 https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-3/SRR023/23153/SRR23153408/SRR23153408.lite.1 SRX19104005 GSM6945989 RNA-Seq cDNA TRANSCRIPTOMIC PAIRED 0 0 ILLUMINA Illumina NovaSeq 6000 SRP418448 PRJNA925859 925859 SRS16516316 simple 9606 Homo sapiens GSM6945989 no BIOENGINEERING, MCGILL UNIVERSITY SRA1577397 public 2A05EC83142012AF6604D97735E5C525 BB93DA9E1D5CB9253C154ED23EAAFA33 32812829 TNBC cells from MDA-MB-231 cell line, no treatment, Day 4 [C2R1] Bioengineering, McGill University 9606 SRS16516316 GSM6945989 MDA-MB-231 Triple Negative Breast Cancer WT MDA-MB-231 no treatment SAMN32812830 SRR23153409 2023-02-15T21:36:26Z 2023-01-20T12:54:09Z 39305587 7939728574 39305587 202 2474 https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-3/SRR023/23153/SRR23153409/SRR23153409.lite.1 SRX19104004 GSM6945988 RNA-Seq cDNA TRANSCRIPTOMIC PAIRED 0 0 ILLUMINA Illumina NovaSeq 6000 SRP418448 PRJNA925859 925859 SRS16516313 simple 9606 Homo sapiens GSM6945988 no BIOENGINEERING, MCGILL UNIVERSITY SRA1577397 public D6E9DC77671A6F1F1FAC67767FAD29BE 2D9D3A5C831F4ED400E2C2C871C62462 32812830 TNBC cells from MDA-MB-231 cell line, no treatment, Day 2 [C1R2] Bioengineering, McGill University 9606 SRS16516313 GSM6945988 MDA-MB-231 Triple Negative Breast Cancer WT MDA-MB-231 no treatment SAMN32812831 SRR23153410 2023-02-15T21:36:26Z 2023-01-20T13:03:50Z 79813860 16122399720 79813860 202 4985 https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-3/SRR023/23153/SRR23153410/SRR23153410.lite.1 SRX19104003 GSM6945987 RNA-Seq cDNA TRANSCRIPTOMIC PAIRED 0 0 ILLUMINA Illumina NovaSeq 6000 SRP418448 PRJNA925859 925859 SRS16516314 simple 9606 Homo sapiens GSM6945987 no BIOENGINEERING, MCGILL UNIVERSITY SRA1577397 public A3356E4FDD2D666CACEA11A5914FF9F6 9CB2A52A3543D735F93E47354DC5E498 32812831 TNBC cells from MDA-MB-231 cell line, no treatment, Day 2 [C1R1] Bioengineering, McGill University 9606 SRS16516314 GSM6945987 MDA-MB-231 Triple Negative Breast Cancer WT MDA-MB-231 no treatment